Redalpine Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Essay

Redalpine published its Q4 2026 market view, arguing the current market punishes narrative and rewards fundamentals, and that now is a good time to invest in European technology.

Redalpine

RedalpineRedalpine

redalpine.comSEP 29, 2026

SEP 29, 2026

Investment

Redalpine co-led Arlequin AI's €28M Series A alongside OTB Ventures. Arlequin builds topological neural network AI for security, defense, and intelligence analysis. Used by governments across Europe.

Arlequin AI

Arlequin AI Redalpine

redalpine.comSEP 2026

SEP 2026

Investment

Redalpine invested in Cambridge Aerospace's $300M Series C through its Summit Fund. Cambridge Aerospace builds autonomous interceptors (Skyhammer) for air defense, founded by Steven Barrett (former MIT, now Cambridge).

Cambridge Aerospace

Cambridge Aerospace Redalpine

redalpine.comSEP 2026

SEP 2026

Milestone

Proxima Fusion raised €411M at a €2.4B valuation, becoming Europe's best-funded fusion company. Redalpine led their seed round in 2024 and doubled down in this round.

Proxima Fusion

Proxima Fusion Redalpine

redalpine.comJUL 2026

JUL 2026

Investment

Redalpine led telli's $15M seed round. telli builds AI voice agents for B2C customer operations, with Charlie as an AI coworker. Used by Sky, Enpal, Vaillant Group.

telli

telli Redalpine

redalpine.comJUL 2026

JUL 2026

Investment

Redalpine backed microagi's $55M seed round (largest ever by a German startup), led by Hummingbird Ventures with Northzone, LocalGlobe, and Village Global. microagi builds Atlas, a robotics deployment platform for European factories.

MicroAGI

MicroAGI Redalpine

redalpine.comJUL 2026

JUL 2026

Exit

Memo Therapeutics exited to Ipsen Global. Redalpine portfolio company in frontier science & biotech.

Memo Therapeutics

Memo Therapeutics Redalpine

redalpine.comJUN 2026

JUN 2026

3 investments· MAY 2026 – JUN 2026Show all

Investment

Co-led Tokura's seed round alongside Heal Capital to build infrastructure for ambulatory surgery centers and the Tokura OS in Germany.

Tokura

Tokura Redalpine

redalpine.comJUN 2026

JUN 2026

Investment

Continued support in Apoha's $36M Series A led by Singular with Draper Associates; Redalpine has backed Apoha since the seed round in 2023. Apoha's platform resolves molecular States as a data class for pharma and materials science.

Apoha

Apoha Redalpine

redalpine.comJUN 2026

JUN 2026

Investment

Backed Helical, a bio foundation models company building a virtual AI lab to power reproducible drug discovery.

Helical

Helical Redalpine

redalpine.comMAY 2026

MAY 2026

Essay

Published essay on what constitutes defensible competitive moats in the AI era, part of the Redalpine x Sifted European Dynamism report.

The real moat in the age of AI

Redalpine

redalpine.comMAR 2026

MAR 2026

Essay

Published thesis identifying six sectors where Europe has structural advantages to lead the next wave of technological innovation.

European Dynamism: six sectors where Europe can lead

Redalpine

redalpine.comMAR 2026

MAR 2026

Investment

Participated in Nscale's $2B Series C — the largest in European history, valuing the company at $14.6B — led by Aker ASA and 8090 Industries, with NVIDIA, Citadel, and others. Invested via the Redalpine Summit Fund.

Nscale

Nscale Redalpine

redalpine.comMAR 2026

MAR 2026

News

Opened a London office alongside the close of RAC VII, expanding Redalpine's European footprint to include the UK alongside existing bases in Zug and Berlin.

Redalpine opens London office

Redalpine

businesscloud.co.ukAUG 2024

AUG 2024

Page 1 of 2

Redalpine | Activity | F4